Open AccessArterial-phase contrast-enhanced ultrasonography for evaluating anti-angiogenesis treatment: A pilot study
Author(s) -
Keiko Yoshida,
Tomihiko Hirokawa,
Fuminori Moriyasu,
Longzhong Liu,
Guangjian Liu,
Masahiko Yamada,
Yumiko Imai
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v17.i8.1045
Subject(s) - medicine , angiogenesis , sorafenib , ultrasound , pathological , parenchyma , ultrasonography , intensity (physics) , contrast enhanced ultrasound , nuclear medicine , microbubbles , liver tumor , pathology , urology , radiology , hepatocellular carcinoma , physics , quantum mechanics
To verify whether arterial-phase contrast-enhanced ultrasonography (CEUS) of tumor parenchymal tissue is useful for evaluation of anti-angiogenesis agents.